3cs9
From Proteopedia
(Difference between revisions)
m (Protected "3cs9" [edit=sysop:move=sysop]) |
|||
| Line 1: | Line 1: | ||
[[Image:3cs9.png|left|200px]] | [[Image:3cs9.png|left|200px]] | ||
| - | <!-- | ||
| - | The line below this paragraph, containing "STRUCTURE_3cs9", creates the "Structure Box" on the page. | ||
| - | You may change the PDB parameter (which sets the PDB file loaded into the applet) | ||
| - | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | ||
| - | or leave the SCENE parameter empty for the default display. | ||
| - | --> | ||
{{STRUCTURE_3cs9| PDB=3cs9 | SCENE= }} | {{STRUCTURE_3cs9| PDB=3cs9 | SCENE= }} | ||
===Human ABL kinase in complex with nilotinib=== | ===Human ABL kinase in complex with nilotinib=== | ||
| - | |||
| - | <!-- | ||
| - | The line below this paragraph, {{ABSTRACT_PUBMED_15710326}}, adds the Publication Abstract to the page | ||
| - | (as it appears on PubMed at http://www.pubmed.gov), where 15710326 is the PubMed ID number. | ||
| - | --> | ||
{{ABSTRACT_PUBMED_15710326}} | {{ABSTRACT_PUBMED_15710326}} | ||
| Line 24: | Line 13: | ||
*[[Nilotinib|Nilotinib]] | *[[Nilotinib|Nilotinib]] | ||
*[[Proto-oncogene tyrosine-protein kinase|Proto-oncogene tyrosine-protein kinase]] | *[[Proto-oncogene tyrosine-protein kinase|Proto-oncogene tyrosine-protein kinase]] | ||
| - | *[[User:Matt Whelihan|User:Matt Whelihan]] | ||
==Reference== | ==Reference== | ||
Revision as of 19:36, 25 July 2012
Contents |
Human ABL kinase in complex with nilotinib
Template:ABSTRACT PUBMED 15710326
About this Structure
3cs9 is a 4 chain structure of Proto-oncogene tyrosine-protein kinase with sequence from Homo sapiens. Full crystallographic information is available from OCA.
See Also
Reference
- Weisberg E, Manley PW, Breitenstein W, Bruggen J, Cowan-Jacob SW, Ray A, Huntly B, Fabbro D, Fendrich G, Hall-Meyers E, Kung AL, Mestan J, Daley GQ, Callahan L, Catley L, Cavazza C, Azam M, Neuberg D, Wright RD, Gilliland DG, Griffin JD. Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl. Cancer Cell. 2005 Feb;7(2):129-41. PMID:15710326 doi:S1535-6108(05)00028-0
Categories: Homo sapiens | Non-specific protein-tyrosine kinase | Cowan-Jacob, S W. | Fabbro, D. | Fendrich, G. | Liebetanz, J. | Manley, P. | Abl | Abl kinase wt in complex with nvp-amn107 | Amn107 | Atp-binding | Cell adhesion | Cytoskeleton | Kinase | Lipoprotein | Magnesium | Manganese | Metal-binding | Myristate | Nilotinib | Nucleotide-binding | Nucleus | Phosphoprotein | Proto-oncogene | Sh2 domain | Sh3 domain | Transferase | Tyrosine-protein kinase
